Tuesday, August 24, 2010

Pharma social marketing and the data its provides

Pin It Now!
Bill Harriss of the Sigma Marketing Group commented on the winning uphill climb of social media marketing regulations and the FDA. He believes that Pharma is winning the battle, but in addition, the rich data that can come from online analytics that supplement offline data about the behavior of patients in addition to their conversion and adherence rates.

Not to mention this brief filed with the US District court:
The Washington Legal Foundation (WLF) and Pfizer filed a brief with the U.S. District Court in April requesting to limit the FDA’s guidance to prevent the free speech of drug manufacturers on social media sites such as blogs, Facebook and Twitter.

Do you believe that Pharma should be granted free speech when it comes to social media marketing? What benefits and drawbacks could this have on Pharma marketing industry and their customers?
Post a Comment